Skip to Main Content

Paper Details

Case report: JAK inhibition as promising treatment option of fatal RVCLS due to mutation (pVAL235Glyfs6).
0
2023
C, JAK, PBMCs, RVCLS, cerebral leukoencephalopathy, janus kinase, mRNA, pVAL235Glyfs6, patient, peripheral blood monocular cells, retinal vasculopathy, ruxolitinib, woman
Author NameAffiliation
Marcus AltfeldLeibniz Institute for Virology
  • 1 - 1

Datasets

Release 1.2